Kissei Pharmaceutical Co., Ltd.
KSPHF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $156 | $157 | $115 | $118 |
| - Cash | $25 | $23 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $2 |
| Enterprise Value | $132 | $135 | $116 | $120 |
| Revenue | $88 | $76 | $67 | $65 |
| % Growth | 16.9% | 12% | 3.2% | – |
| Gross Profit | $44 | $37 | $0 | $0 |
| % Margin | 49.9% | 49.4% | 0.3% | 0.4% |
| EBITDA | $20 | $19 | $3 | $2 |
| % Margin | 22.9% | 24.8% | 4.4% | 3.6% |
| Net Income | $12 | $11 | $11 | $13 |
| % Margin | 13.5% | 14.8% | 15.6% | 19.8% |
| EPS Diluted | 274.21 | 246.58 | 228.31 | 280.2 |
| % Growth | 11.2% | 8% | -18.5% | – |
| Operating Cash Flow | $7 | -$2 | -$0 | $0 |
| Capital Expenditures | -$5 | -$2 | -$0 | -$0 |
| Free Cash Flow | $1 | -$4 | -$0 | -$0 |